Starlight Cardiovascular Awarded $2.16M NIH SBIR Phase II Grant from National Heart, Lung, and Blood Institute

Award supports design and preclinical testing of pediatric stent SAN DIEGO, March 22, 2023 /PRNewswire/ — Starlight Cardiovascular, Inc., a medical device company developing pediatric cardiovascular devices, announced that it has been awarded a Small Business Innovation Research (SBIR)…

Click here to view original post